Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;25(6):755-761.
doi: 10.22038/IJBMS.2022.64170.14133.

Cigarette smoke extract stimulates human pulmonary artery smooth muscle cell proliferation: Role of inflammation and oxidative stress

Affiliations

Cigarette smoke extract stimulates human pulmonary artery smooth muscle cell proliferation: Role of inflammation and oxidative stress

Juan Wang et al. Iran J Basic Med Sci. 2022 Jun.

Abstract

Objectives: Cigarette smoke may play a direct role in proliferation of human pulmonary artery smooth muscle cells (HPASMCs). However, the mechanism involved and the effect of interventions remain unclear. We aimed to evaluate the effect of cigarette smoke extract (CSE) on HPASMCs, explore the role of inflammation and oxidative stress, and the effects of Tempol and PDTC in this process.

Materials and methods: HPASMCs were subjected to normal control (NC), CSE, CSE+Tempol (CSE+T), and CSE+PDTC (CSE+P) groups. Proliferation of HPASMCs was measured by CCK-8 and Western blot. TNF-α, IL-6, MDA, and SOD levels were determined by ELISA and commercial kits. Nuclear translocation of NF-κB p65 was evaluated by western blot.

Results: 1%, 2.5%, and 5% CSE all promoted proliferation of HPASMCs, and effect of 1% CSE was the most significant, however, 7.5% and 10% CSE inhibited viability of cells (all P<0.05). Compared with the NC group, TNF-α, IL-6, and MDA levels increased, SOD activity decreased (all P<0.05), and NF-κB p65 expression in nuclei increased (P=0.04) in the CSE group. Tempol and PDTC inhibited the proliferation of HPASMCs induced by CSE (all P<0.05). And compared with the CSE group, TNF-α, IL-6, and MDA levels in CSE+T and CSE+P groups decreased, while SOD activity increased (all P<0.05). Tempol reduced the expression of NF-κB p65 in nuclei but did not achieve a significant difference (P=0.08). PDTC inhibited the nuclear translocation of NF-κB p65 (P=0.03).

Conclusion: CSE stimulates HPASMCs proliferation in a certain concentration range. The CSE-induced proliferation of HPASMCs involved excessive inflammatory response and oxidative stress. Tempol and PDTC attenuate these effects of CSE on HPASMCs.

Keywords: Cigarette smoking; Inflammation; NF-κB; Oxidative stress; Pulmonary arterial - hypertension.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to declare.

Figures

Figure 1
Figure 1
The HPASMCs were treated with increasing concentrations of CSE for 24 hr. Cell proliferation was analyzed by CCK-8 assay. The data were shown as mean±standard deviation from five duplicated experiments. aP<0.05 compared with NC group, bP<0.01 compared with 1% CSE group, cP<0.01 compared with 2.5% CSE group, dP<0.01 compared with 5% CSE group, eP<0.01 compared with 7.5% CSE group
Figure 2
Figure 2
HPASMCs were pretreated with Tempol or PDTC before exposure to 1% CSE. Cell viability was analyzed by CCK-8 assay. The data were shown as mean±standard deviation from three replicated experiments. *P<0.05 compared with NC group, #P<0.05 compared with 1% CSE group
Figure 3
Figure 3
CSE induced up-expression of α-SMA and nuclear translocation of NF-κB p65 in HPASMCs. a: Western blot analysis showed the expression level of α-SMA, Nuclear NF-κB p65, Cytoplasm NF-κB p65, β-actin, and H3. b: Summarized data showed the average protein level of α-SMA and NF-κB p65 in the nuclear and cytoplasm fraction. *P<0.05 compared with NC group, #P<0.05 compared with 1% CSE group
Figure 4
Figure 4
Effect of CSE on TNF-α (a) and IL-6 (b) levels in the supernatants of HPASMCs with or without Tempol and PDTC. The data were expressed as the mean±standard deviation of three replicated experiments.*P<0.01 compared with NC group, #P<0.01 compared with 1% CSE groupC: normal control; PDTC: pyrrolidine dithiocarbamate; HPASMCs: human pulmonary artery smooth muscle cells; CSE: cigarette smoke extract
Figure 5
Figure 5
Levels of MDA concentration (a) and SOD activity (b) in different exposure conditions. The data were expressed as the mean±standard deviation of three replicated experiments.*P<0.05 compared with NC group, #P<0.05 compared with 1% CSE group

Similar articles

Cited by

References

    1. Karnati S, Seimetz M, Kleefeldt F, Sonawane A, Madhusudhan T, Bachhuka A, et al. Chronic obstructive pulmonary disease and the cardiovascular system: Vascular repair and regeneration as a therapeutic target. Front Cardiovasc Med. 2021;8:649512. - PMC - PubMed
    1. Gao L, Liu J, Hao Y, Zhao Z, Tan H, Zhang J, et al. Chronic intermittent hypobaric hypoxia attenuates monocrotaline-induced pulmonary arterial hypertension via modulating inflammation and suppressing NF-κB/p38 pathway. Iran J Basic Med Sci. 2018;21:244–252. - PMC - PubMed
    1. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314–322. - PubMed
    1. Thabut G, Dauriat G, Stern JB, Logeart D, Lévy A, Marrash-Chahla R, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531–1536. - PubMed
    1. Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019;53:1801914. - PMC - PubMed

LinkOut - more resources